Tweenvest Stocks

Petros Pharmaceuticals, Inc. (OTCPK: PTPI)

Health Care · Pharmaceuticals · US

$0.00

+1.52% today · -85.3% 1Y

Petros Pharmaceuticals, Inc. (OTCPK: PTPI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $141.95K and employs 3 people.

Over the last twelve months the share price has lost 85.3%, trading between 0.00 and 0.03.

Tweenvest scores Petros Pharmaceuticals, Inc. across four factors: quality 45/100, value 47/100. Its strongest factor is value.

PTPI price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$141.95K
Revenue (TTM)
—
P/E
—
EPS
-0.39
Dividend yield
—
Beta (5Y)
1.88
52-week high
$0.03
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
42.37M
Employees
3
Next earnings
—

About Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.

ISIN
US71678J3086
Listed since
Dec 2, 2020
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
GNCC Capital, Inc.OTCPK: GNCP$174.15K$0.00-99.00%
ProPhase Labs, Inc.OTCPK: PRPH$163.08K$0.01-43.04%
NanoSphere Health Sciences Inc.CNSX: NSHS.X$144.31KCA$0.02—
Resonate Blends, Inc.OTCPK: KOAN$143.15K$0.00-25.00%
Allstar Health Brands, Inc.OTCPK: ALST$140.05K$0.00-11.11%
South American Gold Corp.OTCPK: SAGD$130.09K$——
Mystic Holdings, Inc.OTCPK: MSTH$124.91K$——
ViaDerma, Inc.OTCPK: VDRM$123.37K$0.00-50.00%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.